Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

terminated250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Saccharomyces Cerevisiae for Irritable Bowel Syndrome

NCT05149599
terminatednot_applicable

Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

NCT02859493
completednot_applicable

Effect of Saccharomyces Cerevisiae in LDL Cholesterol

NCT02990260
terminatednot_applicable

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

NCT02345096

Clinical Trials (4)

Showing 4 of 4 trials
NCT05149599Phase 1

Saccharomyces Cerevisiae for Irritable Bowel Syndrome

Completed
NCT02859493Not Applicable

Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

Terminated
NCT02990260Not Applicable

Effect of Saccharomyces Cerevisiae in LDL Cholesterol

Completed
NCT02345096Not Applicable

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4